BX Swiss TOP 30 CHF
1.248,01
PKT
+5,02
PKT
+0,40
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
27.01.06 | UBS kaufen | DZ-Bank | |
27.01.06 | Swiss Life buy | Merck Finck & Co | |
26.01.06 | Holcim kaufen | Helaba Trust | |
26.01.06 | Novartis | Zürcher Kantonalbank | |
26.01.06 | Geberit | Zürcher Kantonalbank | |
26.01.06 | Logitech Neutral | First Albany | |
26.01.06 | Lindt in-line | Goldman Sachs | |
25.01.06 | Novartis kaufen | Helaba Trust | |
24.01.06 | ABB (Asea Brown Boveri) verkaufen | Helaba Trust | |
25.01.06 | Novartis neutral | JP Morgan | |
23.01.06 | Novartis buy | Merrill Lynch | |
20.01.06 | Swiss Life outperform | Cheuvreux | |
20.01.06 | Novartis kaufen | Berenberg Bank | |
20.01.06 | Novartis overweight | Morgan Stanley | |
20.01.06 | Swiss Life neutral | UBS | |
20.01.06 | Novartis outperform | HypoVereinsbank | |
24.01.06 | Novartis buy | Jyske Bank | |
23.01.06 | Novartis overweight | Prudential Financial | |
19.01.06 | Novartis reduzieren | Independent Research | |
19.01.06 | Novartis buy | Merrill Lynch | |
20.01.06 | Novartis halten | National-Bank AG | |
19.01.06 | Novartis hold | SEB | |
20.01.06 | Novartis overweight | Prudential Financial | |
20.01.06 | Logitech Hold | Needham & Co | |
18.01.06 | Novartis kaufen | Helaba Trust | |
19.01.06 | Novartis neutral | JP Morgan | |
19.01.06 | Zurich Insurance overweight | JP Morgan | |
18.01.06 | Logitech Market Perform | Avondale Partners | |
18.01.06 | Swiss Life kaufen | M.M. Warburg | |
17.01.06 | Novartis buy | Merrill Lynch | |
20.01.06 | Roche buy | Jyske Bank | |
20.01.06 | Novartis buy | Jyske Bank | |
17.01.06 | Zurich Insurance buy | Merrill Lynch | |
16.01.06 | Adecco SA kaufen | Die Actien-Börse | |
13.01.06 | Novartis kaufen | DZ-Bank | |
13.01.06 | UBS kaufen | DZ-Bank | |
13.01.06 | UBS kaufen | National-Bank AG | |
17.01.06 | Novartis outperform | HypoVereinsbank | |
12.01.06 | Swiss Life | Wirtschaftswoche | |
11.01.06 | Adecco SA outperform | Goldman Sachs |